NIH Seals Virtual Doors for Grant Reviews
Published Date: 10/1/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in November 2025 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers and small businesses seeking funding. No changes to timing or money are announced, but the reviews are key to deciding who gets research grants.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed virtual grant reviews protect IP
The NIH Center for Scientific Review will hold multiple closed virtual meetings from November 12, 2025 through December 11, 2025 to review and evaluate grant applications. The meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) and may include confidential trade secrets, patentable material, and personal information about applicants. If you are a researcher or a small business applying to the listed panels (for example, Small Business: Drug Development on November 17, 2025), your application and related confidential information will be reviewed in these closed sessions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-19108, Office of the Secretary; Notice of Meeting
The Muscular Dystrophy Coordinating Committee is holding a free online meeting on October 31, 2025, to discuss new research plans and ways to help people living with muscular dystrophy. Government officials, patient groups, and industry leaders will join forces to shape a 10-year action plan. Anyone interested can register to watch, ask questions, and share their thoughts—no cost involved!
Next: 2025-19110, Fogarty International Center; Notice of Partially Closed Meeting
The Fogarty International Center is holding a hybrid meeting on February 9-10, 2026, where part of it will be closed to review grant applications, and the rest will be open to the public to discuss current and future projects. This affects researchers applying for grants and anyone interested in global health updates. No registration is needed to join the open session, and special accommodations are available for attendees.